MM RC MULTIPLE MYELOMA RESEARCH CONSORTIUM

Serial Number 98693972
686

Registration Progress

Application Filed
Aug 12, 2024
Under Examination
Approved for Publication
Jul 8, 2025
Published for Opposition
Jul 8, 2025
Registered

Attorney Assistance

Notice of Publication
Due: Aug 07, 2025 4 days

Trademark Image

MM RC MULTIPLE MYELOMA RESEARCH CONSORTIUM

Basic Information

Serial Number
98693972
Filing Date
August 12, 2024
Published for Opposition
July 8, 2025
Drawing Code
3

Status Summary

Current Status
Active
Status Code
686
Status Date
Jul 8, 2025
Application
Pending
Classes
042 044

Rights Holder

The Multiple Myeloma Research Foundation, Inc.

99
Address
383 Main Street, 5th Floor
Norwalk, CT 06851

Ownership History

The Multiple Myeloma Research Foundation, Inc.

Original Applicant
99
Norwalk, CT

The Multiple Myeloma Research Foundation, Inc.

Owner at Publication
99
Norwalk, CT

Legal Representation

Attorney
Jacqueline P. Scheib

USPTO Deadlines

Next Deadline
4 days remaining
Notice of Publication
Due Date
August 07, 2025
Extension Available
Until September 07, 2025
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

26 events
Date Code Type Description Documents
Jul 8, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jul 8, 2025 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jul 2, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jun 5, 2025 ERFR I TEAS REQUEST FOR RECONSIDERATION RECEIVED Loading...
Jun 5, 2025 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jun 5, 2025 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jun 5, 2025 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jun 4, 2025 GNFN O NOTIFICATION OF FINAL REFUSAL EMAILED Loading...
Jun 4, 2025 CNFR R FINAL REFUSAL WRITTEN Loading...
Jun 4, 2025 GNFR O FINAL REFUSAL E-MAILED Loading...
May 2, 2025 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
May 2, 2025 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
May 2, 2025 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Apr 10, 2025 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Apr 10, 2025 GNRT F NON-FINAL ACTION E-MAILED Loading...
Apr 10, 2025 CNRT R NON-FINAL ACTION WRITTEN Loading...
Mar 3, 2025 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Mar 3, 2025 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Mar 3, 2025 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Feb 28, 2025 GNRT F NON-FINAL ACTION E-MAILED Loading...
Feb 28, 2025 CNRT R NON-FINAL ACTION WRITTEN Loading...
Feb 28, 2025 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Feb 26, 2025 DOCK D ASSIGNED TO EXAMINER Loading...
Feb 25, 2025 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Feb 25, 2025 MDSM E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Aug 12, 2024 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
Medical and scientific research featuring the development of therapies and cures for multiple myeloma through scientific collaboration, accelerated research efforts, and the advancement of technologies; and providing on-line information about medical research relating to multiple myeloma via global computer network.
First Use Anywhere: 20140500
First Use in Commerce: 20140500
Class 044
Providing medical information about the treatment of multiple myeloma via a global computer network.
First Use Anywhere: 20140500
First Use in Commerce: 20140500

Additional Information

Design Mark
The mark consists of two letters "M" above the letters "R" and "C" with a border surrounding the letters and is broken at the top let and bottom right corners with the words MULTIPLE MYELOMA RESEARCH CONSORTIUM to the right of the border.
Color Claim
Color is not claimed as a feature of the mark.
Pseudo Mark
MULTIPLE MYELOMA RESEARCH CONSORTIUM MULTIPLE MYELOMA RESEARCH CONSORTIUM

Classification

International Classes
042 044

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"MULTIPLE MYELOMA RESEARCH CONSORTIUM"